News
Cohera Medical over halfway through $25M funding round
June 14, 2010 9:40 am | by Mass Device | CommentsCohera Medical Inc. inches past the midpoint of $25M Series C round. By Brandon Glenn Cohera Medical Inc. has raised $12.7 million in investment funding, nudging past the halfway point to what it hopes will be a $25 million Series C round. The funding comes in the form of...
Upsher-Smith Laboratories Announces Initiation of Phase III Clinical Trial of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
June 14, 2010 9:40 am | by Bio-Medicine.Org | CommentsMAPLE GROVE, Minn. , June 14 /- Upsher-Smith Laboratories, Inc. today announced the initiation of a global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults, using the company's proprietary...
Consumer Information on: Photodynamic Diagnostic D-Light C (PDD) System - P050027
June 14, 2010 9:38 am | by U.S. Food & Drug Administration | CommentsThe Karl Storz Photodynamic Diagnostic D-Light C (PDD) System is used as an optional accessory to white light cystoscopy when used in combination with the diagnostic imaging drug Cysview® (Photocure ASA, a Norwegian pharmaceutical company).
Prostate Cancer: The Father's Day Gift You Never Thought About
June 14, 2010 9:38 am | by Bio-Medicine.Org | CommentsMARLTON, N.J. , June 14 /- While Father's Day gifts range from the touching to the hilarious, the best gift you might give your father or spouse is help and support during the difficult time of a cancer diagnosis. Often men have tremendous difficulties deciding about their treatment,...
Medical device makers drop $20 million on D.C. lobbying
June 14, 2010 9:38 am | by Mass Device | CommentsThe medical device industry spent at least $20 million to lobby lawmakers and federal agencies during the first quarter. The medical device industry once again spent big bucks to ensure its voice was heard in Washington during the first quarter, dropping more than $20 million...
Study: Adding UV light helps form "Missing G" of RNA building blocks
June 14, 2010 7:41 am | by Georgia Tech Institute of Technology | CommentsFor scientists attempting to understand how the building blocks of RNA originated on Earth, guanine has proven to be a particular challenge. By adding UV light to a model prebiotic reaction, researchers have discovered a way to form guanine.
Summary Information for: Karl Storz Photodynamic Diagnostic D-Light C (PDD) System
June 14, 2010 7:35 am | by U.S. Food & Drug Administration | CommentsLabeling, Approval Order, and Summary of Safety and Effectiveness for Karl Storz Photodynamic Diagnostic D-Light C (PDD) System (P050027).
Summary Information for: Elecsys & #xae; PreciControl Anti-HCV for use on the MODULAR ANALYTICS E170 Analyzer Cobas e 601 Immunoassay Analyzer
June 14, 2010 7:35 am | by U.S. Food & Drug Administration | CommentsLabeling, Approval Order, and Summary of Safety and Effectiveness for Elecsys® PreciControl Anti-HCV for use on the MODULAR ANALYTICS E170 Analyzer Cobas e 601 Immunoassay Analyzer (P090009).
Chindex's 4Q net income falls on lower sales
June 14, 2010 6:10 am | by The Associated Press | CommentsChindex International Inc., which sells medical products in China, said Monday its fiscal fourth-quarter net income fell on lower product revenue.In the quarter ended March 31, Chindex's net income fell to $515,000, or 4 cents per share, compared with net income of $3.4 million, or 24 cents per...
Clinical Benefits of Electronic Brachytherapy From Xoft Substantiated for the Treatment of Multiple Cancers
June 14, 2010 5:39 am | by Bio-Medicine.Org | CommentsSUNNYVALE, Calif. , June 14 /- The clinical benefits of isotope-free electronic radiation therapy delivered directly to cancer sites with minimal exposure to surrounding healthy tissue continues to be substantiated by multiple publications, according to Xoft, Inc., developer of the...
MultiCell Hires Clinical Research Organization to Manage MCT-125 Phase IIb Clinical Trial
June 14, 2010 5:38 am | by Bio-Medicine.Org | CommentsWOONSOCKET, R.I. , June 14 /- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has retained Clinical Development & Support Services, Ltd. ( CDSS ) of Cheshire, England to manage its planned Phase IIb clinical trial in the United Kingdom for MCT-125, the Company's lead drug...
Data Management Healthcheck Survey Reveals Health IT's Top Spending Priorities
June 14, 2010 2:38 am | by RealWire | CommentsSecure storage and management of patient data are the most pressing issues as hospitals transition to electronic patient recordsAshtead, UK - 14 June 2010 - Research from a global survey by BridgeHead Software, the Healthcare Storage Virtualization (HSV) company, has revealed that secure...
Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival
June 14, 2010 12:37 am | by Bio-Medicine.Org | CommentsWAYNE, N.J. and EMERYVILLE, Calif. , June 14 /- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that the final analysis of the Phase 3 NExUS ( N SCLC research Ex perience U tilizing S orafenib) trial evaluating Nexavar® (sorafenib)...
Brain MRI in children: 'Incidental' findings yield disclosure dilemmas for doctors, patients
June 13, 2010 8:40 pm | by EurekAlert | Comments(Johns Hopkins Medical Institutions) Pediatricians whose patients undergo "routine" brain MRIs need a plan to deal with findings that commonly reveal unexpected-but-benign anomalies that are unlikely to cause any problem, reports a research team led by Johns Hopkins Children's...
Study confirms favorable long-term prognosis of epilepsy
June 13, 2010 8:40 pm | by EurekAlert | Comments(Wiley-Blackwell) A study conducted by researchers in the Netherlands confirmed that children with idiopathic new-onset epilepsy have a significantly higher rate of remission than those with remote symptomatic epilepsy. Results of this study are now available online in Epilepsia, a...
